Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma

Table 3 Associations between TACE-Iodine 125 treatment and recurrence in patients with early-intermediate HCC before PSM

Characteristics	HR (95%CI)	P value	Adjusted HR (95%CI)	P value
Overall
TACE-RFA	Reference		Reference
TACE-Iodine 125	1.252 (0.805,1.950)	0.319	1.020 (0.645,1.611)	0.934
Child-Pugh A
TACE-RFA	Reference		Reference
TACE-Iodine 125	1.270 (0.749,2.154)	0.374	0.976 (0.566,1.685)	0.932
Child-Pugh B
TACE-RFA	Reference		Reference
TACE-Iodine 125	1.416 (0.598,3.354)	0.429	1.539 (0.560,4.232)	0.403
BCLC A
TACE-RFA	Reference		Reference
TACE-Iodine 125	0.816 (0.352,1.893)	0.636	0.601 (0.234,1.547)	0.291
BCLC B
TACE-RFA	Reference		Reference
TACE-Iodine	1.253 (0.724,2.169)	0.421	1.252 (0.722,2.171)	0.423

Abbreviations: TACE Transarterial chemoembolization; RFA Radiofrequency ablation; BCLC Barcelona Clinic Liver Cancer

ISSN: 1471-230X